Violation Tracker Individual Record
Company:
Otsuka American Pharmaceutical Inc.
Current Parent Company:
Otsuka Pharmaceutical
Penalty:
$4,000,000
Year:
2008
Date:
March 27, 2008
Offense Group:
healthcare-related offenses
Primary Offense:
off-label or unapproved promotion of medical products
Secondary Offense:
False Claims Act and related
Violation Description:
Otsuka American Pharmaceutical Inc., the American subsidiary of Japanese pharmaceutical manufacturer Otsuka Pharmaceutical Co., Ltd., agreed to pay over $4 million to resolve allegations of off-label marketing.
Level of Government:
federal
Action Type:
agency action
Agency:
Justice Department Civil Division
Civil or Criminal Case:
civil
HQ Country of Parent:
Japan
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
